The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Open accessAbstract
After stimulation, dendritic cells (DCs) mature and migrate to draining lymph nodes to induce immune responses. As such, autologous DCs generated ex vivo have been pulsed with tumour antigens and injected back into patients as immunotherapy. While DC vaccines have shown limited promise in the treatment of patients with advanced cancers including glioblastoma, the factors dictating DC vaccine efficacy remain poorly understood. Here we show that pre-conditioning the vaccine site with a potent recall antigen such as tetanus/diphtheria (Td) toxoid can significantly improve the lymph node homing and efficacy of tumour-antigen-specific DCs. To assess the effect of vaccine site pre-conditioning in humans, we randomized patients with glioblastoma to pre-conditioning with either mature DCs or Td unilaterally before bilateral vaccination with DCs pulsed with Cytomegalovirus phosphoprotein 65 (pp65) RNA. We and other laboratories have shown that pp65 is expressed in more than 90% of glioblastoma specimens but not in surrounding normal brain, providing an unparalleled opportunity to subvert this viral protein as a tumour-specific target. Patients given Td had enhanced DC migration bilaterally and significantly improved survival. In mice, Td pre-conditioning also enhanced bilateral DC migration and suppressed tumour growth in a manner dependent on the chemokine CCL3. Our clinical studies and corroborating investigations in mice suggest that pre-conditioning with a potent recall antigen may represent a viable strategy to improve anti-tumour immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Proliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Curran, W. J., Scott, C. B., Horton, J., Nelson, J. S., Weinstein, A. S., Fischbach, A. J., Chang, C. H., Rotman, M., Asbell, S. O., Krisch, R. E., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.9.704 · Cited by 1,310
Regulation of Dendritic Cell Migration to the Draining Lymph Node
Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030448 · Cited by 878
Castellino, F., Huang, A. Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., & Germain, R. N. (2006) · Nature · doi:10.1038/nature04651 · Cited by 855
Human cytomegalovirus infection and expression in human malignant glioma.
Cobbs, C., Harkins, L. E., Samanta, M., Gillespie, G. Y., Bharara, S., King, P. H., Nabors, B., Cobbs, C. G., & Britt, W. J. (2002) · PubMed · Cited by 717
Biological behavior of malignant melanoma cells correlated to their survival in vivo.
Fidler, I. J. (1975) · PubMed · Cited by 599
Gorlia, T., van den Bent, M. J., Hegi, M. E., Mirimanoff, R. O., Weller, M., Cairncross, J. G., Eisenhauer, E., Belanger, K., Brandes, A. A., Allgeier, A., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70384-4 · Cited by 557
Liau, L. M., Prins, R. M., Kiertscher, S. M., Odesa, S. K., Kremen, T. J., Giovannone, A. J., Lin, J.-W., Chute, D. J., Mischel, P. S., Cloughesy, T. F., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0464 · Cited by 543
Yu, J. S., Liu, G., Ying, H., Yong, W. H., Black, K. L., & Wheeler, C. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3505 · Cited by 537
Thurner, B., Röder, C., Dieckmann, D., Heuer, M., Kruse, M., Glaser, A., Keikavoussi, P., Kämpgen, E., Bender, A., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00208-7 · Cited by 482
Mitchell, D. A., Xie, W., Schmittling, R., Learn, C., Friedman, A., McLendon, R. E., & Sampson, J. H. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-035 · Cited by 388
Self-citationNakano, H., Lin, K. L., Yanagita, M., Charbonneau, C., Cook, D. N., Kakiuchi, T., & Gunn, M. D. (2009) · Nature Immunology · doi:10.1038/ni.1707 · Cited by 341
Self-citationConsensus on the role of human cytomegalovirus in glioblastoma
Dziurzynski, K., Chang, S. M., Heimberger, A. B., Kalejta, R. F., McGregor Dallas, S. R., Smit, M., Soroceanu, L., Cobbs, C. S., & Symposium, T. H. A. G. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor227 · Cited by 304
Palucka, A. K., Ueno, H., Connolly, J., Kerneis-Norvell, F., Blanck, J.-P., Johnston, D. A., Fay, J., & Banchereau, J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211309.90621.8b · Cited by 234
Nakano, H., & Gunn, M. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.361 · Cited by 210
Self-citationInaba, K., Swiggard, W. J., Steinman, R. M., Romani, N., Schuler, G., & Brinster, C. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im0307s86 · Cited by 208
Ranganathan, P., Clark, P. A., Kuo, J. S., Salamat, M. S., & Kalejta, R. F. (2011) · Journal of Virology · doi:10.1128/jvi.06097-11 · Cited by 159
Isolation and Generation of Human Dendritic Cells
Nair, S. K., Archer, G. E., & Tedder, T. F. (2012) · Current Protocols in Immunology · doi:10.1002/0471142735.im0732s99 · Cited by 158
Self-citationA simple method to cure established tumors by inflammatory killing of normal cells
Daniels, G. A., Sanchez-Perez, L. A., Díaz, R. M., Kottke, T. J., Thompson, J., Lai, M., Gough, M. J., Karim, M., Bushell, A., Chong, H., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt1007 · Cited by 118
Self-citationSanchez-Perez, L. A., Kottke, T. J., Díaz, R. M., Ahmed, A. U., Thompson, J., Chong, H., Melcher, A. A., Holmen, S. L., Daniels, G. A., & Vile, R. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3216 · Cited by 86
Self-citationMobilization of Dendritic Cell Precursors Into the Circulation by Administration of MIP-1 in Mice
Zhang, Y., Yoneyama, H., Wang, Y., Ishikawa, S., Hashimoto, S., Gao, J., Murphy, P. M., & Matsushima, K. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh024 · Cited by 82
Palucka, A. K., Dhodapkar, M. V., Paczesny, S., Burkeholder, S. B., Wittkowski, K. M., Steinman, R. M., Fay, J. W., & Banchereau, J. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200309000-00006 · Cited by 69
Myers, M. G. (1982) · JAMA · doi:10.1001/jama.1982.03330190042028 · Cited by 65
McLendon, R. E., Cleveland, L., Pegram, C. N., Bigner, S. H., Bigner, D. D., & Friedman, H. S. (1998) · PubMed · Cited by 34
Self-citationMIP-3α and MIP-1α rapidly mobilize dendritic cell precursors into the peripheral blood
He, S., Cao, Q., Yoneyama, H., Ge, H., Zhang, Y., & Zhang, Y. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708420 · Cited by 26
Palucka, A. K., Connolly, J., Ueno, H., Kohl, J., Paczesny, S., Dhodapkar, M. V., Fay, J. W., & Banchereau, J. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-4089-z · Cited by 10
Cited by
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Weller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., Nishikawa, R., Rosenthal, M., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,124
Metadata
- Authors
- Mitchell, D. A., Batich, K. A., Gunn, M. D., Huang, M.-N., Sanchez-Perez, L., Nair, S. K., Congdon, K. L., Reap, E. A., Archer, G. E., Desjardins, A., Friedman, A. H., Friedman, H. S., Herndon II, J. E., Coan, A., McLendon, R. E., Reardon, D. A., Vredenburgh, J. J., Bigner, D. D., & Sampson, J. H.
- Venue
- Nature
- Published
- 2015-03
- Volume
- 519
- Issue
- 7543
- Pages
- 366-369
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2013637325
- Cited by
- 531
- References
- 30
- FWCI
- 28.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.